BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9844679)

  • 1. Non-small cell lung carcinoma: usefulness of unenhanced helical CT of the adrenal glands in an unmonitored environment.
    Macari M; Rofsky NM; Naidich DP; Megibow AJ
    Radiology; 1998 Dec; 209(3):807-12. PubMed ID: 9844679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
    Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
    AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer.
    Benitah N; Yeh BM; Qayyum A; Williams G; Breiman RS; Coakley FV
    Radiology; 2005 May; 235(2):517-22. PubMed ID: 15858092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas?
    Szolar DH; Kammerhuber F
    Radiology; 1997 Feb; 202(2):517-21. PubMed ID: 9015083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
    Porte HL; Ernst OJ; Delebecq T; Métois D; Lemaitre LG; Wurtz AJ
    Eur J Cardiothorac Surg; 1999 May; 15(5):597-601. PubMed ID: 10386403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer.
    Ettinghausen SE; Burt ME
    J Clin Oncol; 1991 Aug; 9(8):1462-6. PubMed ID: 1649268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values?
    Ho LM; Marin D; Neville AM; Barnhart HX; Gupta RT; Paulson EK; Boll DT
    AJR Am J Roentgenol; 2012 Apr; 198(4):840-5. PubMed ID: 22451549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal masses: characterization with delayed contrast-enhanced CT.
    Boland GW; Hahn PF; Peña C; Mueller PR
    Radiology; 1997 Mar; 202(3):693-6. PubMed ID: 9051018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
    Burt M; Heelan RT; Coit D; McCormack PM; Bains MS; Martini N; Rusch V; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):584-8; discussion 588-9. PubMed ID: 8302078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CT assessment of encephalic and suprarenal spread of "operable" pulmonary neoplasms. Preliminary results].
    Volterrani L; Tucci E; Maccherini M; Trusso M; Forzini L; Gotti G
    Radiol Med; 1989 Apr; 77(4):354-5. PubMed ID: 2543039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
    Sane T; Schalin-Jäntti C; Raade M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.